197 related articles for article (PubMed ID: 36181736)
21. Peripheral levels of C-reactive protein, tumor necrosis factor-α, interleukin-6, and interleukin-1β across the mood spectrum in bipolar disorder: A meta-analysis of mean differences and variability.
Solmi M; Suresh Sharma M; Osimo EF; Fornaro M; Bortolato B; Croatto G; Miola A; Vieta E; Pariante CM; Smith L; Fusar-Poli P; Shin JI; Berk M; Carvalho AF
Brain Behav Immun; 2021 Oct; 97():193-203. PubMed ID: 34332041
[TBL] [Abstract][Full Text] [Related]
22. Performance on the Wisconsin card-sorting test and serum levels of glial cell line-derived neurotrophic factor in patients with major depressive disorder.
Zhang X; Ru B; Sha W; Xin W; Zhou H; Zhang Y
Asia Pac Psychiatry; 2014 Sep; 6(3):302-7. PubMed ID: 24436216
[TBL] [Abstract][Full Text] [Related]
23. The relationship between serum brain-derived neurotrophic level and neurocognitive functions in chronic methamphetamine users.
Moaveni A; Fayaz Feyzi Y; Tayebeh Rahideh S; Arezoomandan R
Neurosci Lett; 2022 Feb; 772():136478. PubMed ID: 35085693
[TBL] [Abstract][Full Text] [Related]
24. Cytokines, brain-derived neurotrophic factor and C-reactive protein in bipolar I disorder - Results from a prospective study.
Jacoby AS; Munkholm K; Vinberg M; Pedersen BK; Kessing LV
J Affect Disord; 2016 Jun; 197():167-74. PubMed ID: 26994434
[TBL] [Abstract][Full Text] [Related]
25. Plasma concentrations but not serum concentrations of brain-derived neurotrophic factor are related to pro-inflammatory cytokines in patients undergoing major abdominal surgery.
Chimienti G; Mezzapesa A; Rotelli MT; Lupo L; Pepe G
Clin Biochem; 2012 Jun; 45(9):631-6. PubMed ID: 22425604
[TBL] [Abstract][Full Text] [Related]
26. The importance of selected markers of inflammation and blood-brain barrier damage for short-term ischemic stroke prognosis.
Lasek-Bal A; Jedrzejowska-Szypulka H; Student S; Warsz-Wianecka A; Zareba K; Puz P; Bal W; Pawletko K; Lewin-Kowalik J
J Physiol Pharmacol; 2019 Apr; 70(2):. PubMed ID: 31356182
[TBL] [Abstract][Full Text] [Related]
27. Plasma interleukin-6 and executive function in crack cocaine-dependent women.
Levandowski ML; Hess AR; Grassi-Oliveira R; de Almeida RM
Neurosci Lett; 2016 Aug; 628():85-90. PubMed ID: 27297769
[TBL] [Abstract][Full Text] [Related]
28. Early Initiation of Amphetamine-Type Stimulants (ATS) Use Associated with Lowered Cognitive Performance among Individuals with Co-Occurring Opioid and ATS Use Disorders in Malaysia.
Chooi WT; Mohd Zaharim N; Desrosiers A; Ahmad I; Yasin MAM; Syed Jaapar SZ; Schottenfeld RS; Vicknasingam BK; Chawarski MC
J Psychoactive Drugs; 2017; 49(4):326-332. PubMed ID: 28661714
[TBL] [Abstract][Full Text] [Related]
29. Short communication: Serum levels of brain-derived neurotrophic factor and association with pro-inflammatory cytokines in acute and recovered anorexia nervosa.
Keeler JL; Patsalos O; Chung R; Schmidt U; Breen G; Treasure J; Hubertus H; Dalton B
J Psychiatr Res; 2022 Jun; 150():34-39. PubMed ID: 35349796
[TBL] [Abstract][Full Text] [Related]
30. Inflammatory and neurotrophic factor plasma levels are related to epilepsy independently of etiology.
Alvim MKM; Morita-Sherman ME; Yasuda CL; Rocha NP; Vieira ÉL; Pimentel-Silva LR; Henrique Nogueira M; Barbosa R; Watanabe N; Coan AC; Lopes-Cendes I; Teixeira AL; Cendes F
Epilepsia; 2021 Oct; 62(10):2385-2394. PubMed ID: 34331458
[TBL] [Abstract][Full Text] [Related]
31. Association between childhood trauma exposure and pro-inflammatory cytokines in schizophrenia and bipolar-I disorder.
Quidé Y; Bortolasci CC; Spolding B; Kidnapillai S; Watkeys OJ; Cohen-Woods S; Berk M; Carr VJ; Walder K; Green MJ
Psychol Med; 2019 Dec; 49(16):2736-2744. PubMed ID: 30560764
[TBL] [Abstract][Full Text] [Related]
32. Moderate aerobic training modulates cytokines and cortisol profiles in older adults with cognitive abilities.
Alghadir AH; Gabr SA; Al-Momani M; Al-Momani F
Cytokine; 2021 Feb; 138():155373. PubMed ID: 33248912
[TBL] [Abstract][Full Text] [Related]
33. Impact of high intensity interval exercise on executive function and brain derived neurotrophic factor in healthy college aged males.
Slusher AL; Patterson VT; Schwartz CS; Acevedo EO
Physiol Behav; 2018 Jul; 191():116-122. PubMed ID: 29673858
[TBL] [Abstract][Full Text] [Related]
34. Inflammatory biomarkers and brain health indicators in children with overweight and obesity: The ActiveBrains project.
Adelantado-Renau M; Esteban-Cornejo I; Rodriguez-Ayllon M; Cadenas-Sanchez C; Gil-Cosano JJ; Mora-Gonzalez J; Solis-Urra P; Verdejo-Román J; Aguilera CM; Escolano-Margarit MV; Verdejo-Garcia A; Catena A; Moliner-Urdiales D; Ortega FB
Brain Behav Immun; 2019 Oct; 81():588-597. PubMed ID: 31330300
[TBL] [Abstract][Full Text] [Related]
35. Does COMT genotype influence the effects of d-amphetamine on executive functioning?
Wardle MC; Hart AB; Palmer AA; de Wit H
Genes Brain Behav; 2013 Feb; 12(1):13-20. PubMed ID: 23231539
[TBL] [Abstract][Full Text] [Related]
36. Brain-derived neurotrophic factor, adiponectin, and proinflammatory markers in various subtypes of depression in young men.
Su SC; Sun MT; Wen MJ; Lin CJ; Chen YC; Hung YJ
Int J Psychiatry Med; 2011; 42(3):211-26. PubMed ID: 22439294
[TBL] [Abstract][Full Text] [Related]
37. Dextromethorphan attenuated inflammation and combined opioid use in humans undergoing methadone maintenance treatment.
Chen SL; Lee SY; Tao PL; Chang YH; Chen SH; Chu CH; Chen PS; Lee IH; Yeh TL; Yang YK; Hong JS; Lu RB
J Neuroimmune Pharmacol; 2012 Dec; 7(4):1025-33. PubMed ID: 22990619
[TBL] [Abstract][Full Text] [Related]
38. Amphetamine Modestly Improves Conners' Continuous Performance Test Performance in Healthy Adults.
MacQueen DA; Minassian A; Henry BL; Geyer MA; Young JW; Perry W
J Int Neuropsychol Soc; 2018 Mar; 24(3):283-293. PubMed ID: 29032769
[TBL] [Abstract][Full Text] [Related]
39. Comparing clinical responses and the biomarkers of BDNF and cytokines between subthreshold bipolar disorder and bipolar II disorder.
Wang TY; Lee SY; Chen SL; Chang YH; Wang LJ; Chen PS; Chen SH; Chu CH; Huang SY; Tzeng NS; Li CL; Chung YL; Hsieh TH; Lee IH; Chen KC; Yang YK; Hong JS; Lu RB
Sci Rep; 2016 Jun; 6():27431. PubMed ID: 27270858
[TBL] [Abstract][Full Text] [Related]
40. Use Motives of Patients with Amphetamine-Type Stimulants Use Disorder and Attention-Deficit/Hyperactivity Disorder.
Thurn D; Riedner A; Wolstein J
Eur Addict Res; 2020; 26(4-5):254-262. PubMed ID: 32564027
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
